The Human Genome Project, and recent advances in personalized genomics
Open Access
- 1 February 2015
- journal article
- review article
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. 8, 9-20
Abstract
The language of “personalized medicine” and “personal genomics” has now entered the common lexicon. The idea of personalized medicine is the integration of genomic risk assessment alongside other clinical investigations. Consistent with this approach, testing is delivered by health care professionals who are not medical geneticists, and where results represent risks, as opposed to clinical diagnosis of disease, to be interpreted alongside the entirety of a patient's health and medical data. In this review we consider the evidence concerning the application of such personalized genomics within the context of population screening, and potential implications that arise from this. We highlight two general approaches which illustrate potential uses of genomic information in screening. The first is a narrowly targeted approach in which genetic profiling is linked with standard population-based screening for diseases; the second is a broader targeting of variants associated with multiple single gene disorders, performed opportunistically on patients being investigated for unrelated conditions. In doing so we consider the organization and evaluation of tests and services, the challenge of interpretation with less targeted testing, professional confidence, barriers in practice, and education needs. We conclude by discussing several issues pertinent to health policy, namely: avoiding the conflation of genetics with biological determinism, resisting the “technological imperative”, due consideration of the organization of screening services, the need for professional education, as well as informed decision making and public understanding.Keywords
This publication has 110 references indexed in Scilit:
- Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility GenesThe American Journal of Human Genetics, 2012
- BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 yearsBritish Journal of Cancer, 2012
- Motivators for participation in a whole-genome sequencing study: implications for translational genomics researchEuropean Journal of Human Genetics, 2011
- Genetic testing and common disorders in a public health framework: how to assess relevance and possibilitiesEuropean Journal of Human Genetics, 2011
- Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk ProfilingJournal of General Internal Medicine, 2011
- Genetic testing and common disorders in a public health frameworkEuropean Journal of Human Genetics, 2011
- Effects of communicating DNA-based disease risk estimates on risk-reducing behavioursCochrane Database of Systematic Reviews, 2010
- The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancerHuman Genetics, 2010
- Clinical assessment incorporating a personal genomeThe Lancet, 2010
- An Unwelcome Side Effect of Direct-to-Consumer Personal Genome TestingJAMA, 2008